U.S., May 13 -- ClinicalTrials.gov registry received information related to the study (NCT07580794) titled 'First-in-human Study of HSK56630 in Healthy Subjects' on April 17.
Brief Summary: This is a first-in-human, single ascending dose (SAD) study in healthy adult participants. This is a single-center, randomized, double-blind, placebo-controlled, SAD study to evaluate the safety, tolerability and PK of HSK56630 in healthy adult participants and preliminarily evaluate the PD of HSK56630.
Study Start Date: June 04
Study Type: INTERVENTIONAL
Condition:
Healthy Volunteer
Intervention:
DRUG: HSK56630
Orally administered tablets of HSK56630
DRUG: Placebo
Orally administered tablets of placebo
Recruitment Status: NOT_YET_RECRUITING
...